Cargando…

The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world data

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is one of the most common malignancy with poor prognosis, and the mortality rate remains high. More than 70% of HCC patients have recurrence within 5 years after treatment. The purpose of this study is to evaluate the prognostic values of serum mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bo, Liu, Aixia, Wen, Yi, Yang, Guang, Zhao, Jing, Li, Xiaohan, Mao, Yuanli, Li, Boan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418514/ https://www.ncbi.nlm.nih.gov/pubmed/34403527 http://dx.doi.org/10.1002/jcla.23932

Ejemplares similares

The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma
por: Li, Bo, et al.
Publicado: (2017)

Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of α-fetoprotein, α-fetoprotein-L3, des-γ-carboxy prothrombin, and Golgi protein 73
por: Li, Bo, et al.
Publicado: (2017)

MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor
por: Li, Jiaqi, et al.
Publicado: (2018)

Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors
por: Li, Bo, et al.
Publicado: (2017)

Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma
por: Xu, Yingying, et al.
Publicado: (2021)

Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma
por: Li, Jian-Jun, et al.
Publicado: (2013)

Hepatocellular Carcinoma Surveillance: Benefit of Serum Alfa-fetoprotein in Real-world Practice
por: Lersritwimanmaen, Patharapan, et al.
Publicado: (2018)

Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Prognostic Value of Serum Osteoprotegerin Level in Patients With Hepatocellular Carcinoma Following Surgical Resection
por: Zhang, Chihao, et al.
Publicado: (2021)

Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma
por: Zhi, Qiongjie, et al.
Publicado: (2016)

Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma
por: Li, Chunyan, et al.
Publicado: (2015)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
por: Wu, Wenlong, et al.
Publicado: (2021)

Matrix-Assisted Laser Desorption Ionization: Time of Flight Mass Spectrometry-Identified Models for Detection of ESBL-Producing Bacterial Strains
por: Li, Bo, et al.
Publicado: (2014)

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2019)

BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma
por: Yin, Guozhi, et al.
Publicado: (2016)

Prognostic value of the ALBI grade among patients with single hepatocellular carcinoma without macrovascular invasion
por: Chen, Wenhao, et al.
Publicado: (2021)

Prognostic values of normal preoperative serum cancer markers for gastric cancer
por: Feng, Fan, et al.
Publicado: (2016)

Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection
por: Zhao, Hui, et al.
Publicado: (2016)

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
por: Yang, Xu, et al.
Publicado: (2023)

Serum Fibrinogen Is An Independent Prognostic Factor In Operable Esophageal Squamous Carcinoma: A Real-World Study
por: Zheng, Yan, et al.
Publicado: (2019)

Real-World Use of Immunotherapy for Hepatocellular Carcinoma
por: Sara, Amir, et al.
Publicado: (2023)

Prognostic Value of Preoperative NLR and Vascular Reconstructive Technology in Patients With Pancreatic Cancer of Portal System Invasion: A Real World Study
por: Zhou, Lin, et al.
Publicado: (2021)

Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Ramachandran, Prasanna, et al.
Publicado: (2022)

The Prognostic Value of Lysine Acetylation Regulators in Hepatocellular Carcinoma
por: Sun, Liying, et al.
Publicado: (2022)

Diagnostic and prognostic value of serum Chitinase 3‐like protein 1 in hepatocellular carcinoma
por: Wang, Shuwei, et al.
Publicado: (2022)

The evaluation of prognostic value of serum tumor marker in ovarian tumors
por: Sharief, S, et al.
Publicado: (2015)

Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study
por: Hao, Shuai, et al.
Publicado: (2023)

Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma
por: Xing, Mindan, et al.
Publicado: (2022)

The prognostic value of neuromedin U in patients with hepatocellular carcinoma
por: Li, Qiao, et al.
Publicado: (2020)

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma
por: He, Jingyi, et al.
Publicado: (2020)

MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma
por: Ni, Jun-Sheng, et al.
Publicado: (2019)

Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2015)

The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma
por: Ma, Xuyang, et al.
Publicado: (2021)

Lrig1 is a positive prognostic marker in hepatocellular carcinoma
por: Yang, Bo, et al.
Publicado: (2016)

Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma
por: Ge, Peng-lei, et al.
Publicado: (2020)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

Retraction Note: BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma
por: Yin, Guozhi, et al.
Publicado: (2023)

Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion
por: Zhao, Hui, et al.
Publicado: (2017)

TMEM206 is a potential prognostic marker of hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1vpl7sumvb8c9o80t5lcb1jmnt